[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07173621":3,"trial-entities:NCT07173621":121,"trial-summary:NCT07173621":126},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":22,"study_type":26,"primary_purpose":27,"phases":28,"enrollment_info":30,"interventions":33,"primary_outcomes":39,"secondary_outcomes":50,"sex":51,"minimum_age":52,"maximum_age":53,"healthy_volunteers":14,"eligibility_criteria":54,"std_ages":71,"locations":74,"central_contacts":83,"overall_officials":84,"references":85,"see_also_links":108},"NCT07173621","25-SURG-34","Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach","ENROLLING_BY_INVITATION","2027-12-01","2025-09","2026-08-03","2025-11-24","Sarasota Memorial Health Care System","OTHER",false,"The purpose of this study is to understand how placing Amnioeffect on patients having transcutaneous thyroid or parathyroid surgery affects surgery scar appearance, pain, and the ability to swallow and compare it to patients who do not have anything placed during surgery. The Food and Drug Administration regulates the use of Amnioeffect for homologous use. Both Amnioeffect application and no Amnioeffect application are considered standard of care; however, for the purpose of this study, the use of Amnioeffect during surgery will be considered the intervention, and no Amnioeffect application will be the standard of care.","A product called AMNIOEFFECT has been developed as a barrier intended for use in the treatment of acute and chronic wounds, providing a protective environment to support the healing process. Manufactured by the company MIMEDX, it is a placental-based allograft made of lyophilized human amnion\u002Fintermediate\u002Fchorion membrane (LHACM). During the study, 334 patients who are to undergo transcutaneous thyroid or parathyroid surgery will be recruited to participate over a one-year period. Using a randomized control approach, the study would be conducted to evaluate the impact of AMNIOEFFECT placed over the strap muscle closure before the subcutaneous tissues and skin are reapproximated, compared to standard of care on post-operative pain, swallowing ability, and cosmesis (conferring of beauty) as indicated by scar appearance.",[18,19,20,21],"Thyroid; Wound","Parathyroid Diseases","Surgical Incision","Incision",[23,24,25],"thyroid","parathyroid","surgery","INTERVENTIONAL","TREATMENT",[29],"NA",{"count":31,"type":32},334,"ESTIMATED",[34],{"type":13,"name":35,"description":36,"armGroupLabels":37},"Amnioeffect","Amnioeffect is a placental-based allograft made of lyophilized human amnion\u002Fintermediate\u002Fchorion membrane (LHACM)",[38],"Amnioeffect Application",[40,44,47],{"measure":41,"description":42,"timeFrame":43},"Improvement of scar appearance","Measured by use of the Vancouver Scar Scale; scores rating on vascularity, pigmentation, pliability, and height. Total score ranges from 0-13, with 0 being \"normal\" appearance.","Pre-procedure, 1 month post procedure, 3 months post procedure",{"measure":45,"description":46,"timeFrame":43},"Determine swallowing effectiveness","Measured by use of the SWAL-QOL (Swallowing Quality of Life) score; this survey uses a Likert scale rating to ask questions regarding swallowing difficulties and associated quality of life impacts. Higher scores reflect lower impact on quality of life; lower scores would indicate higher impact.",{"measure":48,"description":49,"timeFrame":43},"Improvement in Pain Score","Measured by use of the Visual Analog Scale; scoring 0 for no pain-10 for unbearable pain.",[],"ALL","18 Years",null,{"inclusion":55,"exclusion":59,"raw_text":70},[56,57,58],"Adults 18 years or older","Patients undergoing thyroid\u002Fparathyroid surgery via a transcutaneous incision","Participants must be willing and able to consent and take part in the study",[60,61,62,63,64,65,66,67,68,69],"Patients \\\u003C 18 years old","Pregnant patients","Patients with a history of keloid scarring","Patients who refuse blood products","Previous neck surgery","Patients on immunosuppressive medications (steroids, immune modulators, etc.)","Patients with a known sensitivity to aminoglycoside antibiotics","Patients with an active or latent infection","Patients with a disorder that would create an unacceptable risk of post-operative complications","Subjects may be excluded at the discretion of the physician(s) based on their clinical judgment and\u002For if the health or safety of the participant may be potentially impacted by taking part in this study","Inclusion Criteria:\n\n* Adults 18 years or older\n* Patients undergoing thyroid\u002Fparathyroid surgery via a transcutaneous incision\n* Participants must be willing and able to consent and take part in the study\n\nExclusion Criteria:\n\n* Patients \\\u003C 18 years old\n* Pregnant patients\n* Patients with a history of keloid scarring\n* Patients who refuse blood products\n* Previous neck surgery\n* Patients on immunosuppressive medications (steroids, immune modulators, etc.)\n* Patients with a known sensitivity to aminoglycoside antibiotics\n* Patients with an active or latent infection\n* Patients with a disorder that would create an unacceptable risk of post-operative complications\n* Subjects may be excluded at the discretion of the physician(s) based on their clinical judgment and\u002For if the health or safety of the participant may be potentially impacted by taking part in this study",[72,73],"ADULT","OLDER_ADULT",[75],{"facility":12,"city":76,"state":77,"zip":78,"country":79,"geoPoint":80},"Sarasota","Florida","34239","United States",{"lat":81,"lon":82},27.33643,-82.53065,[],[],[86,90,93,96,99,102,105],{"pmid":87,"type":88,"citation":89},"34256121","BACKGROUND","Yilmaz S, Habibi HA, Yildiz A, Altunbas H. Thyroid Embolization for Nonsurgical Treatment of Nodular Goiter: A Single-Center Experience in 56 Consecutive Patients. J Vasc Interv Radiol. 2021 Oct;32(10):1449-1456. doi: 10.1016\u002Fj.jvir.2021.06.025. Epub 2021 Jul 10.",{"pmid":91,"type":88,"citation":92},"25004246","Watt T, Cramon P, Hegedus L, Bjorner JB, Bonnema SJ, Rasmussen AK, Feldt-Rasmussen U, Groenvold M. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab. 2014 Oct;99(10):3708-17. doi: 10.1210\u002Fjc.2014-1322. Epub 2014 Jul 8.",{"pmid":94,"type":88,"citation":95},"30221137","Sonbol HS. Extracellular Matrix Remodeling in Human Disease. J Microsc Ultrastruct. 2018 Jul-Sep;6(3):123-128. doi: 10.4103\u002FJMAU.JMAU_4_18.",{"pmid":97,"type":88,"citation":98},"25176107","Koob TJ, Lim JJ, Zabek N, Massee M. Cytokines in single layer amnion allografts compared to multilayer amnion\u002Fchorion allografts for wound healing. J Biomed Mater Res B Appl Biomater. 2015 Jul;103(5):1133-40. doi: 10.1002\u002Fjbm.b.33265. Epub 2014 Aug 30.",{"pmid":100,"type":88,"citation":101},"32580594","Joshi CJ, Hassan A, Carabano M, Galiano RD. Up-to-date role of the dehydrated human amnion\u002Fchorion membrane (AMNIOFIX) for wound healing. Expert Opin Biol Ther. 2020 Oct;20(10):1125-1131. doi: 10.1080\u002F14712598.2020.1787979. Epub 2020 Jul 20.",{"pmid":103,"type":88,"citation":104},"19041821","Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):901-11. doi: 10.1016\u002Fj.beem.2008.09.019.",{"pmid":106,"type":88,"citation":107},"37581037","Cheng KL, Liang KW, Lee HL, Wang HY, Shen CY. Thyroid artery embolization of large solitary symptomatic benign thyroid nodules through transradial approach. Quant Imaging Med Surg. 2023 Aug 1;13(8):5355-5361. doi: 10.21037\u002Fqims-22-1385. Epub 2023 May 30.",[109,112,115,118],{"label":110,"url":111},"AMNIOEFFECT PRODUCT BROCHURE","https:\u002F\u002Fwww.mimedx.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002FUS-LS-2100002-v2.0-AMNIOEFFECT-PRODUCT-BROCHURE-vF.pdf",{"label":113,"url":114},"AMNIOEFFECT Application Guide","https:\u002F\u002Fwww.mimedx.com\u002Fwp-content\u002Fuploads\u002F2023\u002F11\u002FUS-LS-2200005-v1.0_AMNIOEFFECT-Application-Guide.pdf",{"label":116,"url":117},"Processing","https:\u002F\u002Fwww.mimedx.com\u002Fprocessing\u002F",{"label":119,"url":120},"Spine and Neurosurgery","https:\u002F\u002Fwww.mimedx.com\u002Fspine-and-neurosurgery\u002F",{"nct_id":4,"conditions":122,"biomarkers":125},[123,124],"Parathyroid Gland Disorder","Thyroid Gland Disorder",[],{"nct_id":4,"found":14,"summary":53,"prompt_version":53}]